NantHealth Inc. Stock News

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its first q

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2020 first quarter on Thursday, May

Anyone researching NantHealth, Inc. (NASDAQ:NH) might want to consider the historical volatility of the share price...

These exciting stocks to buy for aggressive investors might be small, but they have massive growth potential when the pandemic clears up.

NantHealth (NASDAQ:NH) and Bitauto (NYSE:BITA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, ri

Q4 2019 NantHealth Inc Earnings Call

NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today the appointment of Deanna L. Wise, Senior Vice President and Chief Information Office

StoneCo (NASDAQ:STNE) and NantHealth (NASDAQ:NH) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their divi

In this article we are going to estimate the intrinsic value of NantHealth, Inc. (NASDAQ:NH) by taking the expected...

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2019.

NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today two expanded programs with Eviti Connect®, NantHealth’s healthcare payer solution

NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare technology company, announced today that Dr. Patrick Soon-Shiong, Chairman and CEO, has been chosen to keynote

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 fourth quarter on Friday, Febru

Trivago (NASDAQ:TRVG) and NantHealth (NASDAQ:NH) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of thei

NantOmics, LLC, the leader in molecular analysis, and NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today the publication of a peer-revie